Add Company
Join Now

Seneca Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Seneca Therapeutics's estimated annual revenue is currently $1.9M per year.(i)
  • Seneca Therapeutics's estimated revenue per employee is $186,000

Employee Data

  • Seneca Therapeutics has 10 Employees.(i)
  • Seneca Therapeutics grew their employee count by 0% last year.

Seneca Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Founder, President, Chief Scientific OfficerReveal Email/Phone
3
Human Resources and Business Operations Manager at Seneca Therapeutics, Inc.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M7-12%N/AN/A
#2
$4M3881%N/AN/A
#3
N/A7627%N/AN/A
#4
$0.9M50%N/AN/A
#5
$1.1M833%N/AN/A
#6
$10.9M617%N/AN/A
#7
$0.7M929%N/AN/A
#8
$4M20-5%N/AN/A
#9
$1.7M1122%N/AN/A
#10
$7.6M492%N/AN/A
Add Company

What Is Seneca Therapeutics?

Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus. SVV-001 is already in Phase I/II and has a clinical safety record in humans. SVV-001 binds to the TEM8 receptor which is common in many solid tumors like breast cancer, lung cancer and neuroendocrine tumors. SVV-001 is also being considered as a viral vector for gene therapy targeting the TEM8 receptor in solid tumors.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M10N/AN/A
#2
$0.7M1011%N/A
#3
$1M10-9%N/A
#4
$2M100%N/A
#5
$0.7M10-23%N/A